ArticlePediatric cardiology2026
Outcomes of Neonates and Infants with Vocal Fold Mobility Impairment After Cardiac Surgery.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeVocal fold mobility impairment (VFMI) due to recurrent laryngeal nerve injury is a well-described but under-recognized complication of congenital heart surgery (CHS) in pediatric patients, with significant potential additional burden of care. Neonates and infants who underwent CHS at a single center between September 1st, 2020 and June 30th, 2025 and were diagnosed with post-operative VFMI were included. Patients were classified as Clancy I through IV based on their anatomic characteristics for congenital cardiac lesions. Propensity score matching was performed to identify a subset of cardiac surgical patients without VFMI to evaluate associations between VFMI and postoperative outcomes. A total of 77 out of total 667 patients (11.5%) had VFMI. Clancy class II was most represented (n = 38, 49.4%), followed by class I (22, 28.6%), class IV (15, 19.5%), and class III (2, 2.6%). Patients with VFMI had longer median (IQR) post-operative hospital length of stay at 28 days (17-49) vs. 12 (6-30); p < 0.001) and more often required post-operative ventilation [66 (85.7%) vs. 168 (72.7%); p = 0.042] compared to those without VFMI. At discharge, fewer VFMI patients tolerated full enteral feeds 44 (57.1%) vs. 163 (80.7%) and VFMI patients had more gastrostomy tubes 15 (19.5%) vs. 14 (6.9%) and with a nasogastric tubes 17 (22.1%) vs. 24 (11.9%); p < 0.001. Intervention with vocal cord injection was not associated with differences in postoperative length of stay or incidence of successful PO feeding at discharge. These findings highlight the substantial additional clinical burden associated with VFMI in pediatric cardiac surgery patients, underscoring the importance of early recognition and multidisciplinary management.
Indexed as
Identifiers
42435211What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.